Conferences and symposiums Mini-symposium: Advances in Biomedicine

"Gut stem cell dependencies define organoid growth factor conditions"

Hans Clevers, Distinguished Professor at Utrecht University, research group leader at Princess Maxima Center for Pediatric Oncology, and guest scientist/advisor at the Hubrecht Institute. The Clevers group studies the molecular mechanisms of tissue development and cancer of various organs using organoids made from adult Lgr5 stem cells.

"Mapping the Human Body One Cell at a Time"

Sarah Teichmann, Professor at the University of Cambridge and Cambridge Stem Cell Institute, is one of the co-founders of the Human Cell Atlas, a global initiative bringing together thousands of scientists to ‘create a comprehensive reference map of the types and properties of all human cells, the fundamental unit of life, as a basis for understanding, diagnosing, monitoring and treating health and disease’ (HCA mission statement).  The Teichmann Group studies the composition of human tissues in both healthy and disease states using single cell and spatial genomics, often using cutting-edge methods.

 
"Next generation neuromodulation to prevent ventricular arrhythmias"

David Paterson is a Fellow of Merton College at the University of Oxford and head of the Department of Physiology, Anatomy and Genetics at Oxford. Paterson is best known for his work in cardiac neurobiology, linking the nervous system to heart rhythm.

 
"Pregnancy in women with heart disease"

Jolien Roos, Professor of Cardiology at the Erasmus MC in Rotterdam, The Netherlands.  She is director of the Department of Adult Congenital Heart Disease. Her clinical work and research involves Congenital Heart Disease, Aortic disease and Pregnancy and maternal cardiac disease.

"Towards a Multiplexed Platform to Detect Functional anti-GPCR Autoantibodies"

Thomas Sakmar is a professor and senior physician at Rockefeller University, studying the biology and chemistry of heptahelical G protein-coupled receptors (GPCRs). The laboratory has pioneered novel methods, including genetic code expansion to introduce unnatural amino acids into expressed receptors, as a tool for GPCR-targeted drug discovery.  These receptors are also the targets for approximately one-third of therapeutic drugs. The Sakmar laboratory examines the molecular mechanisms by which G protein-coupled receptors work and develops new technologies to advance drug discovery targeting cancer, inflammation, and autoimmune disorders.

Host

Professor Sten Linnarsson, Department of Medical Biochemistry and Biophysics, and Dean of Campus Solna